
|Articles|January 12, 2023
Phesi Releases Results of Global Analysis of Clinical Trials Conducted in 2021
Analysis shows breast cancer was the most extensively studied disease area in previous year.
Advertisement
Phesi has released the results of its global analysis of all clinical trials conducted in 2021. The data show that breast cancer was the most studied disease area, followed by COVID-19. Overall, oncology had a strong presence in the top five, which also included non-small cell lung cancer, solid tumors, and multiple myeloma.
Read more about the analysis
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Recruitment in the Age of AI: Q&A with John Worden, Javara
2
Why Seizure Counts Alone Can't Define Success in Epilepsy Trials
3
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
4
Lab Orchestration Is Not What You Think It Is
5




